Cytokines as potential biomarkers of liver toxicity

Cancer Biomarkers

Volumn 1, Issue 1, 2005, Pages 29-39

  Lacour, Sandrine ^a,c   Gautier, Jean Charles ^a   Pallardy, Marc ^b   Roberts, Ruth ^a,b  

^a SANOFI   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c ASTRAZENECA   (United Kingdom)

Author keywords

biomarkers; cytokines; drugs; hepatotoxicity; inflammatory reaction

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

ANIMAL; BIOLOGICAL MODEL; CHEMICALLY INDUCED DISORDER; DISEASE PREDISPOSITION; DRUG EFFECT; HUMAN; LIVER; LIVER DISEASE; PHYSIOLOGY; REVIEW; SPECIES DIFFERENCE;

ANIMALS; BIOLOGICAL MARKERS; CYTOKINES; DISEASE SUSCEPTIBILITY; HUMANS; LIVER; LIVER DISEASES; MODELS, BIOLOGICAL; SPECIES SPECIFICITY;

EID: 37149029916     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2005-1105     Document Type: Review

References (135)

1. S. Chitturi and J. George, Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs, Semin Liver Dis 22(2) (2002), 169-183.
2. M.A. Friedman, J. Woodcock, M.M. Lumpkin, J.E. Shuren, A.E. Hass and L.J. Thompson, The safety of newly approved medicines: do recent market removals mean there is a problem? JAMA 281(18) (1999), 1728-1734.
3. D.J. Graham, C.R. Drinkard and D. Shatin, Incidence of idiopathic acute liver failure and hospitalized liver injury in patients treated with troglitazone, Am J Gastroenterol 98(1) (2003), 175-179.
4. M.T. Smith, Mechanisms of troglitazone hepatotoxicity, Chem Res Toxicol 16(6) (2003), 679-687.
5. J.G. Bessems and N.P. Vermeulen, Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches, Crit Rev Toxicol 31(1) (2001), 55-138.
6. H. Jaeschke, G.J. Gores, A.I. Cederbaum, J.A. Hinson, D. Pessayre and J.J. Lemasters, Mechanisms of hepatotoxicity, Toxicol Sci 65(2) (2002), 166-176.
7. D. Keppler, R. Lesch,W. Reutter and K. Decker, Experimental hepatitis induced by D-galactosamine, Exp Mol Pathol 9(2) (1968), 279-290.
8. G.M. Ledda-Columbano, P. Coni, M. Curto, L. Giacomini, G. Faa, S. Oliverio et al., Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide, Am J Pathol 139(5) (1991), 1099-1109.
9. S.D. Nelson, Mechanisms of the formation and disposition of reactive metabolites that can cause acute liver injury, Drug Metab Rev 27(1-2) (1995), 147-177.
10. J.H. Alix, Molecular aspects of the in vivo and in vitro effects of ethionine, an analog of methionine, Microbiol Rev 46(3) (1982), 281-295.
11. D.P. Williams, N.R. Kitteringham, D.J. Naisbitt, M. Pirmohamed, D.A. Smith and B.K. Park, Are chemically reactive metabolites responsible for adverse reactions to drugs? Curr Drug Metab 3(4) (2002), 351-366.
12. N. Kaplowitz, Drug-induced liver disorders: implications for drug development and regulation, Drug Saf 24(7) (2001), 483-490.
13. W.M. Lee, Drug-induced hepatotoxicity, N Engl J Med 349(5) (2003), 474-485.
14. J.F.Kerr, A.H.Wyllie and A.R. Currie, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br J Cancer 26(4) (1972), 239-257.
15. P. Meier and J. Silke, Programmed cell death: Superman meets Dr Death, Nat Cell Biol 5(12) (2003), 1035-1038.
16. G.S. Salvesen and V.M. Dixit, Caspases: intracellular signaling by proteolysis, Cell 91(4) (1997), 443-446.
17. J.S. Gujral, T.R. Knight, A. Farhood, M.L. Bajt and H. Jaeschke, Mode of cell death after acetaminophen overdose in mice: apoptosis or oncotic necrosis?, Toxicol Sci 67(2) (2002), 322-328.
18. J.S. Gujral, A. Farhood and H. Jaeschke, Oncotic necrosis and caspase-dependent apoptosis during galactosamine-induced liver injury in rats, Toxicol Appl Pharmacol 190(1) (2003), 37-46.
19. H. Jaeschke and J.J. Lemasters, Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury, Gastroenterology 125(4) (2003), 1246-1257.
20. M. Leist, F. Gantner, I. Bohlinger, P.G. Germann, G. Tiegs and A. Wendel, Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest, J Immunol 153(4) (1994), 1778-1788.
21. M. Leist, F. Gantner, G. Kunstle, I. Bohlinger, G. Tiegs, H. Bluethmann et al., The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure, Mol Med 2(1) (1996), 109-124.
22. M. Leist, F. Gantner, H. Naumann, H. Bluethmann, K. Vogt, R. Brigelius-Flohe et al., Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins, Gastroenterology 112(3) (1997), 923-934.
23. R.S. Mangipudy, P.S. Rao, A. Andrews, T.J. Bucci, F.A.Witzmann and H.M. Mehendale, Dose-dependent modulation of cell death: apoptosis versus necrosis in thioacetamide hepatotoxicity, Inter J Toxicol 17(2) (1998), 193-210.
24. N. Kaplowitz, Mechanisms of liver cell injury, J Hepatol 32(1 Suppl) (2000), 39-47.
25. N. Kaplowitz, Cell death at the millennium. Implications for liver diseases, Clin Liver Dis 4(1) (2000), 1-23.
26. N. Kaplowitz, Biochemical and cellular mechanisms of toxic liver injury, Semin Liver Dis 22(2) (2002), 137-144.
27. G.M. Adamson and A.W. Harman, Oxidative stress in cultured hepatocytes exposed to acetaminophen, Biochem Pharmacol 45(11) (1993), 2289-2294.
28. H. Jaeschke, T.R. Knight and M.L. Bajt, The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity, Toxicol Lett 144(3) (2003), 279-288.
29. N. Kaplowitz and H. Tsukamoto, Oxidative stress and liver disease, Prog Liver Dis 14 (1996), 131-159.
30. G.L. Kedderis, Biochemical basis of hepatocellular injury, Toxicol Pathol 24(1) (1996), 77-83.
31. L.P. James, P.R. Mayeux and J.A. Hinson, Acetaminopheninduced hepatotoxicity, Drug Metab Dispos 31(12) (2003), 1499-1506.
32. N. Kaplowitz, Drug-induced liver injury, Clin Infect Dis 38(Suppl 2) (2004), S44-S48.
33. N.R. Pumford, N.C. Halmes and J.A. Hinson, Covalent binding of xenobiotics to specific proteins in the liver, Drug Metab Rev 29(1-2) (1997), 39-57.
34. M.J. Czaja, Induction and regulation of hepatocyte apoptosis by oxidative stress, Antioxid Redox Signal 4(5) (2002), 759-767.
35. Z.X. Liu and N. Kaplowitz, Immune-mediated drug-induced liver disease, Clin Liver Dis 6(3) (2002), 467-486.
36. J.J. Lemasters, V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis, Am J Physiol 276(1 Pt 1) (1999), G1-G6.
37. S. Levin, T.J. Bucci, S.M. Cohen, A.S. Fix, J.F. Hardisty, E.K. LeGrand et al., The nomenclature of cell death: recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists, Toxicol Pathol 27(4) (1999), 484-490.
38. S.Y. Proskuryakov, A.G. Konoplyannikov and V.L. Gabai, Necrosis: a specific form of programmed cell death? Exp Cell Res 283(1) (2003), 1-16.
39. M.J. Arends, A.H. McGregor and A.H. Wyllie, Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes, Am J Pathol 144(5) (1994), 1045-1057.
40. S. Desagher, A. Osen-Sand, A. Nichols, R. Eskes, S. Montessuit, S. Lauper et al., Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis, J Cell Biol 144(5) (1999), 891-901.
41. H. Li, H. Zhu, C.J. Xu and J.Yuan, Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis, Cell 94(4) (1998), 491-501.
42. M. Leist, B. Single, A.F. Castoldi, S. Kuhnle and P. Nicotera, Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis, J Exp Med 185(8) (1997), 1481-1486.
43. P. Nicotera and G. Melino, Regulation of the apoptosisnecrosis switch, Oncogene 23(16) (2004), 2757-2765.
44. J.A. Lawson, M.A. Fisher, C.A. Simmons, A. Farhood and H. Jaeschke, Inhibition of Fas receptor (CD95)-induced hepatic caspase activation and apoptosis by acetaminophen in mice, Toxicol Appl Pharmacol 156(3) (1999), 179-186.
45. R.S. Mangipudy and H.M. Mehendale, Temporal changes in tissue repair upon repeated exposure to thioacetamide, Toxicol Appl Pharmacol 149(2) (1998), 254-257.
46. F.R. Balkwill and F. Burke, The cytokine network, Immunol Today 10(9) (1989), 299-304.
47. L.C. Borish and J.W. Steinke, 2. Cytokines and chemokines, J Allergy Clin Immunol 111(2 Suppl) (2003), S460-S475.
48. K. Pfeffer, Biological functions of tumor necrosis factor cytokines and their receptors, Cytokine Growth Factor Rev 14(3-4) (2003), 185-191.
49. M.J. Cameron and D.J. Kelvin, Cytokines and chemokines-their receptors and their genes: an overview, Adv Exp Med Biol 520 (2003), 8-32.
50. G. Ramadori and T. Armbrust, Cytokines in the liver, Eur J Gastroenterol Hepatol 13(7) (2001), 777-784.
51. K.J. Simpson, N.W. Lukacs, L. Colletti, R.M. Strieter and S.L. Kunkel, Cytokines and the liver, J Hepatol 27(6) (1997), 1120-1132.
52. T. Kisseleva, S. Bhattacharya, J. Braunstein and C.W. Schindler, Signaling through the JAK/STAT pathway, recent advances and future challenges, Gene 285(1-2) (2002), 1-24.
53. M.U. Martin and H. Wesche, Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family, Biochim Biophys Acta 1592(3) (2002), 265-280.
54. M. Karin and Y. Ben Neriah, Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity, Annu Rev Immunol 18 (2000), 621-663.
55. M.I. Luster, P.P. Simeonova, R. Gallucci and J. Matheson, Tumor necrosis factor alpha and toxicology, Crit Rev Toxicol 29(5) (1999), 491-511.
56. D. Andres, I. Sanchez-Reus, M. Bautista and M. Cascales, Depletion of Kupffer cell function by gadolinium chloride attenuates thioacetamide-induced hepatotoxicity. Expression of metallothionein and HSP70, Biochem Pharmacol 66(6) (2003), 917-926.
57. H. Ding, R. Peng, E. Reed and Q.Q. Li, Effects of Kupffer cell inhibition on liver function and hepatocellular activity in mice, Int J Mol Med 12(4) (2003), 549-557.
58. H. Ding, J.A. Huang, J. Tong, X. Yu and J.P. Yu, Influence of Kupffer cells on hepatic signal transduction as demonstrated by second messengers and nuclear transcription factors, World J Gastroenterol 9(11) (2003), 2519-2522.
59. O. Holst, A.J. Ulmer, H. Brade, H.D. Flad and E.T. Rietschel, Biochemistry and cell biology of bacterial endotoxins, FEMS Immunol Med Microbiol 16(2) (1996), 83-104.
60. D.L. Laskin and J.D. Laskin, Role of macrophages and inflammatory mediators in chemically induced toxicity, Toxicology 160(1-3) (2001), 111-118.
61. H.R. Michie, K.R. Manogue, D.R. Spriggs, A. Revhaug, S. O'Dwyer, C.A. Dinarello et al., Detection of circulating tumor necrosis factor after endotoxin administration, N Engl J Med 318(23) (1988), 1481-1486.
62. D. Frankova and Z. Zidek, IFN-gamma-induced TNF-alpha is a prerequisite for in vitro production of nitric oxide generated in murine peritoneal macrophages by IFN-gamma, Eur J Immunol 28(3) (1998), 838-843.
63. A.K. Garg and B.B. Aggarwal, Reactive oxygen intermediates in TNF signaling, Mol Immunol 39(9) (2002), 509-517.
64. N. Lavnikova, J.C. Drapier and D.L. Laskin, A single exogenous stimulus activates resident rat macrophages for nitric oxide production and tumor cytotoxicity, J Leukoc Biol 54(4) (1993), 322-328.
65. S.F. Liu, X. Ye and A.B. Malik, Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes, Circulation 100(12) (1999), 1330-1337.
66. N.W. Lukacs, R.M. Strieter, V.M. Elner, H.L. Evanoff, M.D. Burdick and S.L. Kunkel, Intercellular adhesion molecule-1 mediates the expression of monocyte-derived MIP-1 alpha during monocyte-endothelial cell interactions, Blood 83(5) (1994), 1174-1178.
67. N.W. Lukacs, R.M. Strieter, V.M. Elner, H.L. Evanoff, M.D. Burdick and S.L. Kunkel, Production of chemokines, interleukin-8 and monocyte chemoattractant protein-1, during monocyte: endothelial cell interactions, Blood 86(7) (1995), 2767-2773.
68. M.H. Schoemaker, J.E. Ros, M. Homan, C. Trautwein, P. Liston, K. Poelstra et al., Cytokine regulation of pro-and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis, J Hepatol 36(6) (2002), 742-750.
69. A. Colell, C. Garcia-Ruiz, M. Miranda, E. Ardite, M. Mari, A. Morales et al., Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor, Gastroenterology 115(6) (1998), 1541-1551.
70. A. Colell, O. Coll, C. Garcia-Ruiz, R. Paris, C. Tiribelli, N Kaplowitz et al., Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factorinduced cell death by replenishing mitochondrial glutathione, Hepatology 34(5) (2001), 964-971.
71. K. Matsumaru, C. Ji and N. Kaplowitz, Mechanisms for sensitization to TNF-induced apoptosis by acute glutathione depletion in murine hepatocytes, Hepatology 37(6) (2003), 1425-1434.
72. H. Nagai, K. Matsumaru, G. Feng and N. Kaplowitz, Reduced glutathione depletion causes necrosis and sensitization to tumor necrosis factor-alpha-induced apoptosis in cultured mouse hepatocytes, Hepatology 36(1) (2002), 55-64.
73. M.E. Blazka, J.L. Wilmer, S.D. Holladay, R.E. Wilson and M.I. Luster, Role of proinflammatory cytokines in acetaminophen hepatotoxicity, Toxicol Appl Pharmacol 133(1) (1995), 43-52.
74. C.R. Gardner, J.D. Laskin, D.M. Dambach, H. Chiu, S.K. Durham, P. Zhou et al., Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators, Toxicol Appl Pharmacol 192(2) (2003), 119-130.
75. K.J. Simpson, N.W. Lukacs, A.H. McGregor, D.J. Harrison, R.M. Strieter and S.L. Kunkel, Inhibition of tumour necrosis factor alpha does not prevent experimental paracetamolinduced hepatic necrosis, J Pathol 190(4) (2000), 489-494.
76. C.R. Gardner, J.D. Laskin, D.M. Dambach, M. Sacco, S.K. Durham, M.K. Bruno et al., Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-alpha and interleukin-10, Toxicol Appl Pharmacol 184(1) (2002), 27-36.
77. M. Bourdi, Y. Masubuchi, T.P. Reilly, H.R. Amouzadeh, J.L. Martin, J.W. George et al., Protection against acetaminopheninduced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase, Hepatology 35(2) (2002), 289-298.
78. L.P. James, S.S. McCullough, L.W. Lamps and J.A. Hinson, Effect of N-acetylcysteine on acetaminophen toxicity in mice: relationship to reactive nitrogen and cytokine formation, Toxicol Sci 75(2) (2003), 458-467.
79. Y. Ishida, T. Kondo, T. Ohshima, H. Fujiwara, Y. Iwakura and N. Mukaida, A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury, FASEB J 16(10) (2002), 1227-1236.
80. U.M. Apte, P.B. Limaye, D. Desaiah, T.J. Bucci, A.Warbritton and H.M. Mehendale, Mechanisms of increased liver tissue repair and survival in diet-restricted rats treated with equitoxic doses of thioacetamide, Toxicol Sci 72(2) (2003), 272-282.
81. A. Akbay,K. Cinar, O. Uzunalimoglu, S. Eranil, C.Yurdaydin, H. Bozkaya et al., Serum cytotoxin and oxidant stress markers in N-acetylcysteine treated thioacetamide hepatotoxicity of rats, Hum Exp Toxicol 18(11) (1999), 669-676.
82. R. Bruck, R. Oren, H. Shirin, H. Aeed, M. Papa, Z. Matas et al., Hypothyroidism minimizes liver damage and improves survival in rats with thioacetamide induced fulminant hepatic failure, Hepatology 27(4) (1998), 1013-1020.
83. M. Shito, U.J. Balis, R.G. Tompkins, M.L. Yarmush and M. Toner, A fulminant hepatic failure model in the rat: involvement of interleukin-1beta and tumor necrosis factor-alpha, Dig Dis Sci 46(8) (2001), 1700-1708.
84. R.F. Stachlewitz, V. Seabra, B. Bradford, C.A. Bradham, I. Rusyn, D. Germolec et al., Glycine and uridine prevent Dgalactosamine hepatotoxicity in the rat: role of Kupffer cells, Hepatology 29(3) (1999), 737-745.
85. H. Oku, H. Nakazato, T. Hori kawa, Y. Tsuruta and R. Suzuki, Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock, Eur J Pharmacol 446(1-3) (2002), 167-176.
86. L. Santucci, S. Fiorucci, M. Chiorean, P.M. Brunori, F.M. Di Matteo, A. Sidoni et al., Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice, Gastroenterology 111(3) (1996), 736-744.
87. S.K. De, R. Silverstein and G.K. Andrews, Hydrazine sulfate protection against endotoxin lethality: analysis of effects on expression of hepatic cytokine genes and an acute-phase gene, Microb Pathog 13(1) (1992), 37-47.
88. Q.L. Tran, I.K. Adnyana, Y. Tezuka, Y. Harimaya, I.O. Saiki, Y. Kurashige et al., Hepatoprotective effect of majonoside R2, the major saponin from Vietnamese ginseng (Panax vietnamensis), Planta Med 68(5) (2002), 402-406.
89. M.Van Dien, K. Takahashi, M.M. Mu, N.Koide, T. Sugiyama, I. Mori et al., Protective effect of wogonin on endotoxininduced lethal shock in D-galactosamine-sensitized mice, Microbiol Immunol 45(11) (2001), 751-756.
90. T. Nakama, S. Hirono, A. Moriuchi, S. Hasuike, K. Nagata, T. Hori et al., Etoposide prevents apoptosis in mouse liver with D-galactosamine/ lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality, Hepatology 33(6) (2001), 1441-1450.
91. F.A. Santos, R.M. Silva, A.R. Tome, V.S. Rao, M.M. Pompeu, M.J. Teixeira et al., 1,8-cineole protects against liver failure in an in-vivo murine model of endotoxemic shock, J Pharm Pharmacol 53(4) (2001), 505-511.
92. P. He, Y. Noda and K. Sugiyama, Green tea suppresses lipopolysaccharide- induced liver injury in d-galactosaminesensitized rats, J Nutr 131(5) (2001), 1560-1567.
93. M.D. Josephs, F.R. Bahjat, K. Fukuzuka, R. Ksontini, C.C. Solorzano, C.K. Edwards III et al., Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNFalpha and not by Fas ligand, Am J Physiol Regul Integr Comp Physiol 278(5) (2000), R1196-R1201.
94. M.E. Krecic-Shepard, D.R. Shepard, D. Mullet, G. Apseloff, S.E.Weisbrode and N. Gerber, Gallium nitrate suppresses the production of nitric oxide and liver damage in a murine model of LPS-induced septic shock, Life Sci 65(13) (1999), 1359-1371.
95. J.J. Jones, J. Fan, A.B. Nathens, A. Kapus, M. Shekhman, J.C. Marshall et al., Redox manipulation using the thiol-oxidizing agent diethyl maleate prevents hepatocellular necrosis and apoptosis in a rodent endotoxemia model, Hepatology 30(3) (1999), 714-724.
96. H. Louis, O. Le Moine, M.O. Peny, B. Gulbis, F. Nisol, M. Goldman et al., Hepatoprotective role of interleukin 10 in galactosamine/lipopolysaccharide mouse liver injury, Gastroenterology 112(3) (1997), 935-942.
97. M.E. Blazka, M.R. Elwell, S.D. Holladay, R.E. Wilson and M.I. Luster, Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha, Toxicol Pathol 24(2) (1996), 181-189.
98. Y. Iimuro, R.M. Gallucci, M.I. Luster, H. Kono and R.G. Thurman, Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat, Hepatology 26(6) (1997), 1530-1537.
99. Y. Ishida, T. Kondo, K. Tsuneyama, P. Lu, T. Takayasu and N. Mukaida, The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in mice, J Leukoc Biol 75(1) (2004), 59-67.
100. S.B. Yee, P.E. Ganey and R.A. Roth, The role of Kupffer cells and TNF-alpha in monocrotaline and bacterial lipopolysaccharide-induced liver injury, Toxicol Sci 71(1) (2003), 124-132.
101. L.A. Morio, H. Chiu, K.A. Sprowles, P. Zhou, D.E. Heck, M.K. Gordon et al., Distinct roles of tumor necrosis factoralpha and nitric oxide in acute liver injury induced by carbon tetrachloride in mice, Toxicol Appl Pharmacol 172(1) (2001), 44-51.
102. P.P. Simeonova, R.M. Gallucci, T. Hulderman, R.Wilson, C. Kommineni, M. Rao et al., The role of tumor necrosis factoralpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride, Toxicol Appl Pharmacol 177(2) (2001), 112-120.
103. N. Van Rooijen and A. Sanders, Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, propamidine, and ethylenediaminetetraacetic acid, Hepatology 23(5) (1996), 1239-1243.
104. R.D. Goldin, I.D. Ratnayaka, C.S Breach, I.N. Brown and S.N.Wickramasinghe, Role of macrophages in acetaminophen (paracetamol)-induced hepatotoxicity, J Pathol 179(4) (1996), 432-435.
105. D.L. Laskin, C.R. Gardner, V.F. Price and D.J. Jollow, Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen, Hepatology 21(4) (1995), 1045-1050.
106. S.L. Michael, N.R. Pumford, P.R. Mayeux, M.R. Niesman and J.A. Hinson, Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species, Hepatology 30(1) (1999), 186-195.
107. C. Ju, T.P. Reilly, M. Bourdi, M.F. Radonovich, J.N. Brady, J.W. George et al., Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice, Chem Res Toxicol 15(12) (2002), 1504-1513.
108. J.A. Hewett, A.E. Schultze, S. VanCise and R.A. Roth, Neutrophil depletion protects against liver injury from bacterial endotoxin, Lab Invest 66(3) (1992), 347-361.
109. J.A. Hewett, P.A. Jean, S.L. Kunkel and R.A. Roth, Relationship between tumor necrosis factor-alpha and neutrophils in endotoxin-induced liver injury, Am J Physiol 265(6 Pt 1) (1993), G1011-G1015.
110. H. Jaeschke, A. Farhood and C.W. Smith, Neutrophilinduced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism, Am J Physiol 261(6 Pt 1) (1991), G1051-G1056.
111. H. Jaeschke, A. Farhood, A.P. Bautista, Z. Spolarics, J.J. Spitzer and C.W. Smith, Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver, Hepatology 17(5) (1993), 915-923.
112. H. Jaeschke, C.W. Smith, M.G. Clemens, P.E. Ganey and R.A. Roth, Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils, Toxicol Appl Pharmacol 139(2) (1996), 213-226.
113. J.M. Pearson, A.E. Schultze, P.A. Jean and R.A. Roth, Platelet participation in liver injury from gram-negative bacterial lipopolysaccharide in the rat, Shock 4(3) (1995), 178-186.
114. J.M. Pearson, A.E. Schultze, K.A. Schwartz, M.A. Scott, J.M. Davis and R.A. Roth, The thrombin inhibitor, hirudin, attenuates lipopolysaccharide- induced liver injury in the rat, J Pharmacol Exp Ther 278(1) (1996), 378-383.
115. J.M. Pearson, A.P. Brown, A.E. Schultze, P.E. Ganey and R.A. Roth, Gadolinium chloride treatment attenuates hepatic platelet accumulation after lipopolysaccharide administration, Shock 5(6) (1996), 408-415.
116. C. Libert, S. Van Bladel, P. Brouckaert, A. Shaw and W. Fiers, Involvement of the liver, but not of IL-6, in IL-1-induced desensitization to the lethal effects of tumor necrosis factor, J Immunol 146(8) (1991), 2625-2632.
117. C. Libert, W. Van Molle, P. Brouckaert and W. Fiers, Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality, J Inflamm 46(3) (1995), 139-143.
118. M. Leist, F. Gantner, S. Jilg and A. Wendel, Activation of the 55 kDa TNF receptor is necessary and sufficient for TNFinduced liver failure, hepatocyte apoptosis, and nitrite release, J Immunol 154(3) (1995), 1307-1316.
119. S.J. Zheng, P.Wang, G. Tsabary and Y.H. Chen, Critical roles of TRAIL in hepatic cell death and hepatic inflammation, J Clin Invest 113(1) (2004), 58-64.
120. L.P. James, P.R. Mayeux and J.A. Hinson, Acetaminopheninduced hepatotoxicity, Drug Metab Dispos 31(12) (2003), 1499-1506.
121. L.W. Weber, M. Boll and A. Stampfl, Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model, Crit Rev Toxicol 33(2) (2003), 105-136.
122. M.G. Swain, C. Appleyard, J. Wallace, H. Wong and T. Le, Endogenous glucocorticoids released during acute toxic liver injury enhance hepatic IL-10 synthesis and release, Am J Physiol 276(1 Pt 1) (1999), G199-G205.
123. G. Tiegs, S.Kusters, G.Kunstle, H. Hentze, A.K. Kiemer and A. Wendel, Ebselen protects mice against T cell-dependent, TNF-mediated apoptotic liver injury, J Pharmacol Exp Ther 287(3) (1998), 1098-1104.
124. H. Louis, O. Le Moine, M.O. Peny, E. Quertinmont, D. Fokan, M. Goldman et al., Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice, Hepatology 25(6) (1997), 1382-1389.
125. A. Ashkenazi, R.C. Pai, S. Fong, S. Leung, D.A. Lawrence, S.A. Marsters et al,. Safety and antitumor activity of recombinant soluble Apo2 ligand, J Clin Invest 104(2) (1999), 155-162.
126. H. Walczak, R.E. Miller, K. Ariail, B. Gliniak, T.S. Griffith, M. Kubin et al., Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo, Nat Med 5(2) (1999), 157-163.
127. M. Jo, T.H. Kim, D.W. Seol, J.E. Esplen, K. Dorko, T.R. Billiar et al., Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand, Nat Med 6(5) (2000), 564-567.
128. D. Lawrence, Z. Shahrokh, S. Marsters, K. Achilles, D. Shih, B. Mounho et al., Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions, Nat Med 7(4) (2001), 383-385.
129. C. Galanos, M.A. Freudenberg and W. Reutter, Galactosamine-induced sensitization to the lethal effects of endotoxin, Proc Natl Acad Sci USA 76(11) (1979), 5939-5943.
130. H. Redl, S. Bahrami, G. Schlag and D.L. Traber, Clinical detection of LPS and animal models of endotoxemia, Immunobiology 187(3-5) (1993), 330-345.
131. K. Decker, D. Keppler and J. Pausch, The regulation of pyrimidine nucleotide level and its role in experimental hepatitis, Adv Enzyme Regul 11 (1973), 205-230.
132. S.K. El Mofty, M.C. Scrutton, A. Serroni, C. Nicolini and J.L. Farber, Early, reversible plasma membrane injury in galactosamine-induced liver cell death, Am J Pathol 79(3) (1975), 579-595.
133. D.E. Amacher, Serum transaminase elevations as indicators of hepatic injury following the administration of drugs, Regul Toxicol Pharmacol 27(2) (1998), 119-130.
134. D.E. Amacher, A toxicologist's guide to biomarkers of hepatic response, Hum Exp Toxicol 21(5) (2002), 253-262.
135. A. Fregia and D.M. Jensen, Evaluation of abnormal liver tests, Compr Ther 20(1) (1994), 50-54.